Quince Therapeutics, Inc. (QNCX): S-3/A filed Aug 5, 2026

Form type

S-3/A

Filing date

Aug 5, 2026

Accession number

0001193125-26-333764

Filer

Quince Therapeutics, Inc. (CIK 1662774)